These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2451560)

  • 41. Regulation of methotrexate polyglutamate accumulation in vitro: effects of cellular folate content.
    Galivan J; Nimec Z; Balinska M
    Biochem Pharmacol; 1983 Nov; 32(21):3244-7. PubMed ID: 6196031
    [No Abstract]   [Full Text] [Related]  

  • 42. Potent inhibition of human folylpolyglutamate synthetase by suramin.
    McGuire JJ; Haile WH
    Arch Biochem Biophys; 1996 Nov; 335(1):139-44. PubMed ID: 8914844
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relative substrate activities of structurally related pteridine, quinazoline, and pyrimidine analogs for mouse liver folylpolyglutamate synthetase.
    Moran RG; Colman PD; Jones TR
    Mol Pharmacol; 1989 Nov; 36(5):736-43. PubMed ID: 2586490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Separation of methotrexate-polyglutamates by capillary electrophoresis and its application to the measurement of gamma-glutamyl hydrolase activity in human leukemia cells in culture].
    Takemura Y; Kobayashi H; Sekiguchi S
    Rinsho Byori; 1996 Jan; 44(1):51-6. PubMed ID: 8691640
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of methotrexate and dihydrofolate polyglutamates in the enhancement of fluorouracil action by methotrexate.
    Fernandes DJ; Moroson BA; Bertino JR
    Cancer Treat Rep; 1981; 65 Suppl 1():29-35. PubMed ID: 6173121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antifolate drug interactions: enhancement of growth inhibition due to the antipurine 5,10-dideazatetrahydrofolic acid by the lipophilic dihydrofolate reductase inhibitors metoprine and trimetrexate.
    Galivan J; Nimec Z; Rhee M; Boschelli D; Oronsky AL; Kerwar SS
    Cancer Res; 1988 May; 48(9):2421-5. PubMed ID: 2965613
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human liver folylpolyglutamate synthetase: biochemical characterization and interactions with folates and folate antagonists.
    Clarke L; Waxman DJ
    Arch Biochem Biophys; 1987 Aug; 256(2):585-96. PubMed ID: 3619447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differing specificities for 4-aminofolate analogues of folylpolyglutamyl synthetase from tumors and proliferative intestinal epithelium of the mouse with significance for selective antitumor action.
    Rumberger BG; Barrueco JR; Sirotnak FM
    Cancer Res; 1990 Aug; 50(15):4639-43. PubMed ID: 2369741
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histone deacetylase inhibitors induce FPGS mRNA expression and intracellular accumulation of long-chain methotrexate polyglutamates in childhood acute lymphoblastic leukemia: implications for combination therapy.
    Leclerc GJ; Mou C; Leclerc GM; Mian AM; Barredo JC
    Leukemia; 2010 Mar; 24(3):552-62. PubMed ID: 20072153
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Folylpolyglutamate synthetase expression in antifolate-sensitive and -resistant human cell lines.
    McGuire JJ; Russell CA
    Oncol Res; 1998; 10(4):193-200. PubMed ID: 9778690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and biologic activity of new side-chain-altered methotrexate and aminopterin analogs with dual inhibitory action against dihydrofolate reductase and folylpolyglutamate synthetase.
    Rosowsky A; Moran RG; Freisheim JH; Bader H; Forsch RA; Solan VC
    NCI Monogr; 1987; (5):145-52. PubMed ID: 3431589
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intracellular pharmacokinetics of methotrexate polyglutamates in human breast cancer cells. Selective retention and less dissociable binding of 4-NH2-10-CH3-pteroylglutamate4 and 4-NH2-10-CH3-pteroylglutamate5 to dihydrofolate reductase.
    Jolivet J; Chabner BA
    J Clin Invest; 1983 Sep; 72(3):773-8. PubMed ID: 6193143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evolution of drug resistance in CCRF-CEM human leukemia cells selected by intermittent methotrexate exposure.
    McGuire JJ; Haile WH; Russell CA; Galvin JM; Shane B
    Oncol Res; 1995; 7(10-11):535-43. PubMed ID: 8866666
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of folate and one-carbon metabolism in mammalian cells. II. Effect of folylpoly-gamma-glutamate synthetase substrate specificity and level on folate metabolism and folylpoly-gamma-glutamate specificity of metabolic cycles of one-carbon metabolism.
    Lowe KE; Osborne CB; Lin BF; Kim JS; Hsu JC; Shane B
    J Biol Chem; 1993 Oct; 268(29):21665-73. PubMed ID: 8408019
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia.
    Barredo JC; Synold TW; Laver J; Relling MV; Pui CH; Priest DG; Evans WE
    Blood; 1994 Jul; 84(2):564-9. PubMed ID: 7517720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formation of methotrexate polyglutamates in rat hepatocytes.
    Gewirtz DA; White JC; Randolph JK; Goldman ID
    Cancer Res; 1979 Aug; 39(8):2914-8. PubMed ID: 455278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of polyglutamation on sensitivity to raltitrexed and methotrexate in relation to drug-induced inhibition of de novo thymidylate and purine biosynthesis in CCRF-CEM cell lines.
    Barnes MJ; Estlin EJ; Taylor GA; Aherne GW; Hardcastle A; McGuire JJ; Calvete JA; Lunec J; Pearson AD; Newell DR
    Clin Cancer Res; 1999 Sep; 5(9):2548-58. PubMed ID: 10499632
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synergistic growth inhibition of rat hepatoma cells exposed in vitro to N10-propargyl-5,8-dideazafolate with methotrexate or the lipophilic antifolates trimetrexate or metoprine.
    Galivan J; Nimec Z; Rhee M
    Cancer Res; 1987 Oct; 47(20):5256-60. PubMed ID: 2958130
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biosynthesis of polyglutamates of folates.
    Scrimgeour KG
    Biochem Cell Biol; 1986 Jul; 64(7):667-74. PubMed ID: 3756000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The biochemical pharmacology of the thymidylate synthase inhibitor, 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
    Jackman AL; Newell DR; Gibson W; Jodrell DI; Taylor GA; Bishop JA; Hughes LR; Calvert AH
    Biochem Pharmacol; 1991 Oct; 42(10):1885-95. PubMed ID: 1741766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.